KLRA

11.1403.80%
JB

Jamie Beth Coleman

Chief Commercial Officer

Ms. Jamie Beth Coleman is Chief Commercial Officer of Kailera Therapeutics, Inc. since January 2025. Prior to joining Kailera, she served at Eli Lilly where she held key roles in brand strategy, consumer marketing and global commercial leadership across therapeutic areas. Most recently, she served as Vice President, U.S. Brand Leader for Zepbound where she executed an accelerated product launch, delivering a market-leading brand for the treatment of obesity. Previously, she was U.S. Brand Leader for Trulicity® as associate vice president, U.S. brand leader—Trulicity®, from September 2020 to May 2022. She also led global brand strategy for Jardiance, which became a leading product in the diabetes market and oversaw the global commercial strategy and execution for Lartruvo for the treatment of solid tumors. Additionally, she directed U.S. consumer marketing strategies for high-profile oncology treatments and held roles at Pfizer and ZS Associates earlier in her career. She holds an M.B.A. from the University of Chicago Booth School of Business and a B.B.A. in Marketing, International Business and Spanish from the University of Wisconsin.

Positions